| Trade Names | |
| Synonyms | |
| Status | |
| Molecule Category | Salt-form |
| UNII | UF6PC17XAV |
| Parent Compound: | ENASIDENIB |
| InChI Key | ORZHZQZYWXEDDL-UHFFFAOYSA-N |
|---|---|
| Smiles | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C20H21F6N7O4S |
| Molecular Weight | 569.49 |
| AlogP | 4.29 |
| Hydrogen Bond Acceptor | 8.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 108.74 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 33.0 |
| Mechanism of Action | Action | Reference |
|---|---|---|
| Isocitrate dehydrogenase [NADP], mitochondrial inhibitor | INHIBITOR | FDA |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Oxidoreductase
|
- | 123.6-318.6 | - | - | - |
|
Protein: Isocitrate dehydrogenase [NADP], mitochondrial Description: Isocitrate dehydrogenase [NADP], mitochondrial Organism : Homo sapiens P48735 ENSG00000182054 |
||||
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3989931 |
| FDA SRS | UF6PC17XAV |
| PubChem | 90480031 |
| SureChEMBL | SCHEMBL16448052 |